全文获取类型
收费全文 | 2608篇 |
免费 | 386篇 |
国内免费 | 24篇 |
专业分类
耳鼻咽喉 | 9篇 |
儿科学 | 82篇 |
妇产科学 | 29篇 |
基础医学 | 1496篇 |
口腔科学 | 42篇 |
临床医学 | 146篇 |
内科学 | 576篇 |
皮肤病学 | 120篇 |
神经病学 | 176篇 |
特种医学 | 7篇 |
外科学 | 91篇 |
综合类 | 58篇 |
现状与发展 | 1篇 |
预防医学 | 17篇 |
眼科学 | 36篇 |
药学 | 96篇 |
中国医学 | 6篇 |
肿瘤学 | 30篇 |
出版年
2024年 | 1篇 |
2023年 | 36篇 |
2022年 | 17篇 |
2021年 | 67篇 |
2020年 | 82篇 |
2019年 | 90篇 |
2018年 | 81篇 |
2017年 | 79篇 |
2016年 | 89篇 |
2015年 | 99篇 |
2014年 | 110篇 |
2013年 | 366篇 |
2012年 | 112篇 |
2011年 | 101篇 |
2010年 | 107篇 |
2009年 | 116篇 |
2008年 | 120篇 |
2007年 | 130篇 |
2006年 | 97篇 |
2005年 | 84篇 |
2004年 | 110篇 |
2003年 | 96篇 |
2002年 | 82篇 |
2001年 | 92篇 |
2000年 | 73篇 |
1999年 | 77篇 |
1998年 | 55篇 |
1997年 | 43篇 |
1996年 | 43篇 |
1995年 | 48篇 |
1994年 | 50篇 |
1993年 | 34篇 |
1992年 | 41篇 |
1991年 | 42篇 |
1990年 | 28篇 |
1989年 | 11篇 |
1988年 | 19篇 |
1987年 | 15篇 |
1986年 | 6篇 |
1985年 | 13篇 |
1984年 | 11篇 |
1983年 | 16篇 |
1982年 | 5篇 |
1981年 | 4篇 |
1980年 | 3篇 |
1979年 | 9篇 |
1978年 | 3篇 |
1977年 | 2篇 |
1976年 | 2篇 |
1968年 | 1篇 |
排序方式: 共有3018条查询结果,搜索用时 31 毫秒
1.
2.
3.
Inhibition of immune cell trafficking to the pancreatic islets during type 1 diabetes (T1D) has therapeutic potential, since targeting of T cell and B cell trafficking has been clinically effective in other autoimmune diseases. Trafficking to the islets is characterized by redundancy in adhesion molecule and chemokine usage, which has not enabled effective targeting to date. Additionally, cognate antigen is not consistently required for T cell entry into the islets throughout the progression of disease. However, myeloid cells are required to enable T cell and B cell entry into the islets, and may serve as a convergence point in the pathways controlling this process. In this review we describe current knowledge of the factors that mediate immune cell trafficking to pancreatic islets during T1D progression. 相似文献
4.
R. Asero A. V. Marzano S. Ferrucci M. Lorini V. Carbonelli M. Cugno 《Clinical and experimental immunology》2020,200(3):242-249
Chronic spontaneous urticaria (CSU) pathogenesis shows a complex and still unclear interplay between immunoglobulin (Ig)G- and IgE-mediated autoimmunity, leading to mast cell and basophil degranulation and wheal formation. The objective of this study was to evaluate at the same time IgE- and IgG-reactivity to well recognized and recently reported autoantigens in CSU patients, and to assess the effects of such reactivity on response to the anti-IgE monoclonal antibody omalizumab. Twenty CSU patients underwent omalizumab treatment. Urticaria activity score 7 (UAS7) was recorded at baseline and at different drug administration time-points for categorizing early-, late- or non-responders. At baseline, sera from the 20 patients and from 20 controls were tested for IgE and IgG autoantibodies to high- and low-affinity IgE receptors (FcεRI and FcεRII), tissue factor (TF) and thyroglobulin (TG) by immunoenzymatic methods. Antibody levels were compared with those of controls and analysed according to response. Eighteen patients were omalizumab responders (11 early and seven late), while two were non-responders. More than 50% of patients had contemporary IgE and IgG to at least to one of the four different autoantigens. Late responders showed higher levels of both anti-TF IgE and IgG than early responders (P = 0·011 and P = 0·035, respectively). Twenty-five per cent of patients had levels of anti-FcεRI IgE, exceeding the upper normal limit, suggesting that it could be a novel auto-allergen in CSU. In CSU, there is an autoimmune milieu characterized by the co-existence of IgE and IgG autoantibodies to the same antigen/allergen, particularly in late responders to omalizumab, possibly explaining the slower response. 相似文献
5.
6.
7.
Judith Wienke Willemijn Janssen Rianne Scholman Hilde Spits Marielle van Gijn Marianne Boes Joris van Montfrans Nicolette Moes Sytze de Roock 《Oncotarget》2015,6(24):20037-20042
Mutations in STAT3 have recently been shown to cause autoimmune diseases through increased lymphoproliferation. We describe a novel Pro471Arg STAT3 mutation in a patient with multiple autoimmune diseases, causing hyperactivation of the Th17 pathway. We show that IL-17 production by primary T cells was enhanced and could not be further increased by IL-6, while IL-10 reduced Th17 cell numbers. Moreover, specific inhibition of STAT3 activation resulted in diminished IL-17 production. We show that the Pro471Arg STAT3 mutation yields both increased levels of IgA and IgG, probably due to high IL-21 levels. When remission was reached through medical intervention, IL-17 levels normalized and the clinical symptoms improved, supporting the idea that STAT3 gain-of-function mutations can cause hyperactivation of the Th17 pathway and thereby contribute to autoimmunity. 相似文献
8.
9.
10.